Cardiomyocyte death is a common feature of many forms of heart disease. Since the myocardium lacks a substantive endogenous regenerative potential, cardiomyocyte death is essentially irreversible. It has recently become apparent that exogenous myocytes can be successfully engrafted into the adult myocardium, thereby increasing the number of cells present in the heart. This procedure may be of considerable therapeutic value if engrafted cells can augment function in a diseased heart. Indeed, strategies aimed at increasing myocyte number was viewed with the highest priority by the NHLBI Special Emphasis Panel on Heart Failure Research and by this RFA. However, several rather formidable issues and obstacles must be addressed before any therapy based on myocyte engraftment can be realized. The five highly integrated Collaborative RO1s proposed herein are designed to directly address these issues. A major goal of the proposed studies is to establish the fate of donor cells following engraftment. Particular emphasis is being placed on identifying factor(s) which enhance donor cell viability (Dr. Kedes), and on determining the degree to which donor and host myocytes can interact (Field and Murry). Other studies (Field, Murry and Hauschka) will establish the relative merits of a variety of different donor cells (fetal cardiomyocytes, skeletal myoblasts, ES- and EC- derived cardiomyocytes, and smooth muscle cells). Particular emphasis will be placed on weighing the issue of donor cell availability versus the functional characteristics of their respective grafts. Functional analyses of the engrafted hearts will rely largely on highly sensitive 2D echocardiography (Kloner). These latter studies will also establish to what degree cellular engraftment has a direct versus indirect effect on cardiac function (that is, participation in contractile force generation versus a positive effect on remodeling). The assembled investigators have established track records in relatively new field of cardiac engraftment, and additionally bring a diverse spectrum of experimental expertise which collectively provides a comprehensive battery of molecular, cellular and functional experimental methods.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061553-07
Application #
6839458
Study Section
Special Emphasis Panel (ZHL1-CSR-F (S1))
Program Officer
Buxton, Denis B
Project Start
1999-01-01
Project End
2005-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
7
Fiscal Year
2005
Total Cost
$268,760
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Reinecke, Hans; Robey, Thomas E; Mignone, John L et al. (2013) Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts. Cardiovasc Pathol 22:91-5
Nourse, Marilyn B; Halpin, Daniel E; Scatena, Marta et al. (2010) VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 30:80-9
Moreno-Gonzalez, Alicia; Korte, F Steven; Dai, Jin et al. (2009) Cell therapy enhances function of remote non-infarcted myocardium. J Mol Cell Cardiol 47:603-13
Anderl, Jeff N; Robey, Thomas E; Stayton, Patrick S et al. (2009) Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res A 88:704-10
Robey, Thomas E; Murry, Charles E (2008) Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol 17:6-13
Sampath, Prabha; Pritchard, David K; Pabon, Lil et al. (2008) A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2:448-60
Laflamme, Michael A; Zbinden, Stephan; Epstein, Stephen E et al. (2007) Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2:307-39
Ueno, Shuichi; Weidinger, Gilbert; Osugi, Tomoaki et al. (2007) Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A 104:9685-90
Laflamme, Michael A; Chen, Kent Y; Naumova, Anna V et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-24
Stevens, Kelly R; Rolle, Marsha W; Minami, Elina et al. (2007) Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts. Hum Gene Ther 18:401-12

Showing the most recent 10 out of 33 publications